資料下載
測量應(yīng)用案例-20221003
閱讀:204 發(fā)布時(shí)間:2022-10-11提 供 商 | 美國布魯克海文儀器公司 | 資料大小 | 1.2MB |
---|---|---|---|
資料圖片 | 下載次數(shù) | 0次 | |
資料類型 | PDF 文件 | 瀏覽次數(shù) | 204次 |
免費(fèi)下載 | 點(diǎn)擊下載 |
Abstract CuFeSe2 nanomaterial with high thermal conversion efficiency, well superparamagnetism, effective x-ray attenuation ability, multifunctional groups and excellent biocompatibility is beneficial to the construction of multimodal imaging probes which can combine various imaging modes to provide a synergistic advantage over a single imaging mode. This study aimed to develop a novel multimodal nanocontrast agent CuFeSe2@diethylenetriaminepentaacetic acid (DTPA)-Gd to obtain imaging information with high specificity, high sensitivity and high contrast. The morphology and physical characteristics of CuFeSe2@DTPA-Gd were detected by transmission electron microscope, scanning electron microscope, x-ray single crystal diffraction, vibrating sample magnetometer and fourier transform infrared spectrometer. The toxicity of CuFeSe2@DTPA-Gd in vivowas evaluated by hematoxylin-eosin staining. The imaging capability of CuFeSe2@DTPA-Gd in vitro and in vivowas evaluated by magnetic resonance imaging (MRI) and computed tomography (CT). This study successfully prepared nanoparticles CuFeSe2@DTPA-Gd, and experimental results in this study demonstrated CuFeSe2@DTPA-Gd is expected to be a useful CT and MRI T1-weighted imaging/T2- weighted imaging three-modal contrast agent in clinic.